Spero Therapeutics (SPRO) Shares Outstanding (Entity) (2016 - 2026)
Spero Therapeutics (SPRO) Shares Outstanding (Entity) (2016 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Entity.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 253.35 Mn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 102.80 Mn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | 62.54 Mn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | 399.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 113.02 Mn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 133.73 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 218.28 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 575.47 Mn |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 252.88 Mn |
| 10 | Spero Therapeutics | 70.14 Mn | 19.37 Mn | - | 58.15 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 58.23 Mn |
| Mar 31, 2026 | 57.89 Mn |
| Dec 31, 2025 | 56.41 Mn |
| Sep 30, 2025 | 56.31 Mn |
| Jun 30, 2025 | 56.19 Mn |
| Mar 31, 2025 | 55.90 Mn |
| Dec 31, 2024 | 54.59 Mn |
| Sep 30, 2024 | 54.31 Mn |
| Jun 30, 2024 | 54.01 Mn |
| Mar 31, 2024 | 53.87 Mn |
| Dec 31, 2023 | 53.00 Mn |
| Sep 30, 2023 | 53.00 Mn |
| Jun 30, 2023 | 52.57 Mn |
| Mar 31, 2023 | 52.57 Mn |
| Dec 31, 2022 | 37.59 Mn |
| Sep 30, 2022 | 42.86 Mn |
| Jun 30, 2022 | 35.07 Mn |
| Mar 31, 2022 | 32.76 Mn |
| Dec 31, 2021 | 32.39 Mn |
| Sep 30, 2021 | 32.22 Mn |